Price
No data yet.
Social Signal Score
Analyst Ratings
15 analystsRevenue
$72.66M+671.51%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- David R. Bailey
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 602
- Beta
- 0.87
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 2.93
Financials
Revenue
$72.66M+671.5%Net Income
$-5.93MEBITDA
$2.20MFree Cash Flow
$1.59MEPS (diluted)
$-0.25Shares Outstanding (diluted)
24.15M+221.5%Operating Expenses
$57.59MCash & Debt
$44.23MReturn of Capital
$0.00Revenue by Segment (annual)
$236.35MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $236.35M | $-39.65M | $-1.69 |
| 2024 | $204.73M | $-37.82M | $-1.64 |
| 2023 | $148.73M | $-20.97M | $-0.92 |
| 2022 | $122.29M | $1.26M | $0.06 |
| 2021 | $98.05M | $-16.26M | $-0.84 |
| 2020 | $71.08M | $-32.94M | $-1.82 |
| 2019 | $72.55M | $-13.73M | $-1.18 |
| 2018 | $57.56M | $-12.03M | $-0.96 |
| 2017 | $45.62M | $-8.93M | $-1.85 |
| 2016 | $37.30M | $-6.57M | $-0.87 |
| 2015 | $31.00M | $-7.89M | $-1.05 |
| 2014 | $23.68M | $-9.55M | $-1.28 |
Valuation
KIDShas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
70+40.00%Social Signal Score
Mentions (16)
- Newsglobenewswire.com·13d ago·Positive
OrthoPediatrics Announces Full Commercial Launch of VerteGlide® Spinal Growth Guidance System Successful Limited Launch Highlights Strong Demand and Adoption of the Company's Innovative Early Onset Scoliosis Solution Successful Limited Launch Highlights Strong Demand and Adoption of the Company's Innovative Early Onset Scoliosis Solution
View source ↗ - Newsglobenewswire.com·20d ago·Neutral
OrthoPediatrics to Participate in Upcoming Conferences WARSAW, Ind., Nov. 02, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in two upcoming investor conferences, held in New York, NY.
View source ↗ - Newszacks.com·23d ago·Positive
All You Need to Know About OrthoPediatrics (KIDS) Rating Upgrade to Buy OrthoPediatrics (KIDS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
View source ↗ - Newsseekingalpha.com·25d ago·Neutral
OrthoPediatrics Corp. (KIDS) Q3 2026 Earnings Call Transcript OrthoPediatrics Corp. ( KIDS ) Q3 2026 Earnings Call October 27, 2026 4:30 PM EDT Company Participants David Bailey - President, CEO & Director Fred Hite - CFO, Principal Financial & Accounting Officer, COO and Director Conference Call Participants Philip Taylor - Gilmartin Group LLC Caitlin Roberts - Canaccord Genuity Corp., Research Division Frederick Wise - Stifel, Nicolaus & Company, Incorporated, Research Division Michael Matson …
View source ↗ - Newsfool.com·26d ago·Positive
OrthoPediatrics: 3 Key Takeaways for Long-Term Investors OrthoPediatrics raised 2026 revenue guidance to $270 million to $273 million. Third-quarter revenue grew 19% year over year to $72.7 million.
View source ↗ - Newsmarketbeat.com·26d ago·Neutral
OrthoPediatrics Q3 Earnings Call Highlights OrthoPediatrics NASDAQ: KIDS reported record third-quarter revenue and raised its full-year sales outlook, citing broad-based demand across its trauma, deformity, scoliosis and specialty bracing businesses, as well as continued progress from recently introduced products.
View source ↗ - Newszacks.com·26d ago·Negative
OrthoPediatrics (KIDS) Reports Q3 Loss, Tops Revenue Estimates OrthoPediatrics (KIDS) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.24 per share a year ago.
View source ↗ - Newsglobenewswire.com·26d ago·Neutral
OrthoPediatrics Announces FDA 510(k) Clearance of PNP | Femur Retrograde Nail System and Completes First Implantations New addition to the Pediatric Nailing Platform expands options for pediatric femoral trauma and deformity correction New addition to the Pediatric Nailing Platform expands options for pediatric femoral trauma and deformity correction
View source ↗ - Newsglobenewswire.com·26d ago·Neutral
OrthoPediatrics Corp. Reports Third Quarter 2026 Financial Results and Increases 2026 Financial Guidance Record Third Quarter 2026 Revenue of $72.7 Million , Up 19% Year-over-Year
View source ↗ - Newsglobenewswire.com·40d ago·Neutral
…ird Quarter Financial Results on October 27, 2026 WARSAW, Ind., Oct. 13, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2026 financial results on Tuesday, October 27, 2026 after the market closes. OrthoPediatrics will host a conference call on Tuesday, October 27, 2026 at 4:30 p.m. ET to disc…
View source ↗ - Newsprnewswire.com·40d ago·Neutral
SOUR PATCH KIDS Declares Halloween is Mischief Season with 13 Days of Mischief SOUR PATCH KIDS to Launch New Halloween Candy and Inspire Mischief-Making on Social Media, Featuring a Partnership with Wingstop EAST HANOVER, N.J., Oct. 13, 2026 /PRNewswire/ -- According to SOUR PATCH KIDS, Halloween is mischief season.
View source ↗ - Newsglobenewswire.com·46d ago·Neutral
OrthoPediatrics Expands Its Lower Extremity Bracing Portfolio with the Launch of OPSB® Knee 'TractorFIX WARSAW, Ind., Oct. 07, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing (“OPSB”) portfolio with a new product launch, the OPSB® Knee 'TractorFIX contracture management orthosis.
View source ↗ - Newsglobenewswire.com·52d ago·Neutral
OrthoPediatrics Sponsors the 10th Pediatric Orthopedic Surgical Techniques Course Milestone program with record attendance brought together 39 participants from 23 institutions across 22 cities and three countries Milestone program with record attendance brought together 39 participants from 23 institutions across 22 cities and three countries
View source ↗ - Newsglobenewswire.com·61d ago·Neutral
OrthoPediatrics Surpasses 1,000 PNP Tibia Nail Implantations WARSAW, Ind., Sept. 22, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the recent implantation of the 1,000th Tibia Nail using its latest Pediatric Nailing Platform (PNP).
View source ↗ - Newsglobenewswire.com·89d ago·Neutral
OrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful Implantations Successful Limited Launch Demonstrates Demand for Innovative Pediatric-Specific Hip Plating Technology Successful Limited Launch Demonstrates Demand for Innovative Pediatric-Specific Hip Plating Technology
View source ↗ - Newsmarketbeat.com·100d ago·Neutral
OrthoPediatrics Sees ‘Inflection Point' as New Products Fuel Record Quarter OrthoPediatrics NASDAQ: KIDS reported record revenue, adjusted EBITDA and number of children helped during the second quarter, as the pediatric orthopedic device company began to see early contributions from its newer “super cycle” products, Chief Executive Officer Dave Bailey said at the Canaccord Genuity Growth Conference.
View source ↗
Earnings
Thu, Feb 25(in 3 months)
Consensus estimate $-0.21 per share
Typical surprise -7.3% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Oct 27$-0.23 vs $-0.21miss
- Tue, Aug 4$-0.26 vs $-0.30beat
- Thu, Apr 30$-0.42 vs $-0.38miss
- Thu, Feb 26$-0.43 vs $-0.37miss
- Tue, Oct 28$-0.24 vs $-0.26beat
- Tue, Aug 5$-0.11 vs $-0.17beat
Estimates and results for KIDS via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by KIDS officers and directors.
- Bought
- $99k
- Sold
- $49.3m
1 trade
39 trades
- Squadron Capital Llcsold
- Pritzker Jennifer N.sold
- Pelizzon David Rsold
- Squadron Capital Llcsold
- Pritzker Jennifer N.sold
- Pelizzon David Rsold
- Squadron Capital Llcsold
- Pritzker Jennifer N.sold
60 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Greg Gianfortehouse · MT00 · disclosed Jun 25, 2020 (7d later)Buy$15,001 - $50,000
- Greg Gianfortehouse · MT00 · disclosed Feb 14, 2020 (30d later)Buy$50,001 - $100,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
